|Depth of cure of resin composites: is the ISO 4049 method suitable for bulk fill materials?|
S Flury, S Hayoz, A Peutzfeldt, J Hüsler, A Lussi
Dental materials 28 (5), 521-528, 2012
|Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the …|
P Ghadjar, S Hayoz, J Bernhard, DR Zwahlen, T Holscher, P Gut
J Clin Oncol 33 (35), 4158-66, 2015
|Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09)|
C Rothermundt, S Hayoz, AJ Templeton, R Winterhalder, RT Strebel, ...
European urology 66 (3), 468-474, 2014
|The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a …|
F Strasser, D Blum, R Von Moos, R Cathomas, K Ribi, S Aebi, D Betticher, ...
Annals of Oncology 27 (2), 324-332, 2016
|A short food literacy questionnaire (SFLQ) for adults: Findings from a Swiss validation study|
CG Krause, S Beer-Borst, K Sommerhalder, S Hayoz, T Abel
Appetite 120, 275-280, 2018
|Impact of weight loss on survival after chemoradiation for locally advanced head and neck cancer: secondary results of a randomized phase III trial (SAKK 10/94)|
P Ghadjar, S Hayoz, F Zimmermann, S Bodis, D Kaul, H Badakhshi, ...
Radiation oncology 10 (1), 21, 2015
|Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III …|
T Ruhstaller, P Thuss-Patience, S Hayoz, S Schacher, JR Knorrenschild, ...
Annals of oncology 29 (6), 1386-1393, 2018
|Preoperative versus postoperative docetaxel–cisplatin–fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 …|
N Fazio, R Biffi, R Maibach, S Hayoz, S Thierstein, P Brauchli, J Bernhard, ...
Annals of Oncology 27 (4), 668-673, 2016
|Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09)|
M Joerger, RHN Van Schaik, ML Becker, S Hayoz, M Pollak, R Cathomas, ...
Prostate cancer and prostatic diseases 18 (2), 167-172, 2015
|Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy|
E Zucca, S Rondeau, A Vanazzi, B Østenstad, UJM Mey, D Rauch, ...
blood 134 (4), 353-362, 2019
|The relationship of health/food literacy and salt awareness to daily sodium and potassium intake among a workplace population in Switzerland|
X Luta, S Hayoz, CG Krause, K Sommerhalder, E Roos, P Strazzullo, ...
Nutrition, Metabolism and Cardiovascular Diseases 28 (3), 270-277, 2018
|Clinical outcome after rectal replacement with side-to-end, colon-J-pouch, or straight colorectal anastomosis following total mesorectal excision: a Swiss prospective …|
WR Marti, G Curti, H Wehrli, F Grieder, M Graf, B Gloor, M Zuber, ...
Annals of surgery 269 (5), 827-835, 2019
|Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study …|
G Henke, M Knauer, K Ribi, S Hayoz, MA Gérard, T Ruhstaller, ...
Trials 19 (1), 1-28, 2018
|Feasibility and acceptance of electronic monitoring of symptoms and syndromes using a handheld computer in patients with advanced cancer in daily oncology practice|
D Blum, D Koeberle, A Omlin, J Walker, R Von Moos, W Mingrone, ...
Supportive Care in Cancer 22 (9), 2425-2434, 2014
|Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10|
P Ghadjar, S Hayoz, J Bernhard, DR Zwahlen, J Stein, T Hölscher, P Gut, ...
Radiotherapy and oncology 126 (2), 257-262, 2018
|Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers|
P Ghadjar, C Pöttgen, D Joos, S Hayoz, M Baumann, S Bodis, W Budach, ...
Strahlentherapie und Onkologie 192 (8), 552-560, 2016
|Prevention of Symptomatic Skeletal Events with Denosumab Administered Every 4 Weeks Versus Every 12 Weeks–A Non-Inferiority Phase III Trial: Sakk 96/12-Reduse|
AJ Templeton, L Stalder, LA Sauvin, J Bernhard, P Brauchli, S Gillessen, ...
Annals of Oncology 25, iv540, 2014
|Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First‐Line Docetaxel: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled …|
R Cathomas, SJ Crabb, M Mark, R Winterhalder, C Rothermundt, T Elliott, ...
The Prostate 76 (16), 1519-1527, 2016
DE Meier, RS Morrison, JC Ahronheim
Practice of Geriatrics, 3rd ed. Philadelphia, PA: WB Saunders Company, 1998
|Intergroup phase III trial of neo-adjuvant chemotherapy, followed by chemoradiation and surgery with and without cetuximab in locally advanced esophageal carcinoma: First …|
T Ruhstaller, PC Thuss-Patience, S Hayoz, S Schacher-Kaufmann, ...
Journal of Clinical Oncology 35 (15_suppl), 4019-4019, 2017